#Ipsen is voluntarily withdrawing its EZH2 inhibitor #Tazverik from sale after a clinical trial suggested a link with #secondarybloodcancers.
0
0
0
0
#Ipsen is voluntarily withdrawing its EZH2 inhibitor #Tazverik from sale after a clinical trial suggested a link with #secondarybloodcancers.